THALOMID Side Effects

6612315-7 | Coagulopathy, Foot Amputation, Necrosis, Peripheral Ischaemia, Thrombosis
on Mar 02, 2010 Female patient from UNITED STATES , weighting 107.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, foot amputation, necrosis, peripheral ischaemia, thrombosis. Thalomid dosage: 200mg Daily Po. Patient was hospitalized.

6611898-0 | Dialysis, Hypotension, Syncope
Patient was taking Thalomid (View Usage). Patient had the following side effects: dialysis (What is dialysis?), hypotension, syncope on Feb 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 135.0 lb, was diagnosed with amyloidosis and. Thalomid dosage: 100 Mg Qd Po. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6611353-8 | Pneumonia
Adverse event was reported on Mar 01, 2010 by a Male patient taking Thalomid (View Usage) (Dosage: 50 Mg Qhs Po) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 223.0 lb, After Thalomid was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6575975-5 | Leukocytoclastic Vasculitis, Renal Failure
on Jan 27, 2010 Female patient from UNITED STATES , 85 years of age, weighting 206.8 lb, was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis, renal failure. Thalomid dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), MOXIFLOXACIN HCL (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), ZOMETA (View Zometa Review and Zometa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.


6572047-0 | Anaemia, Asthenia, Blood Creatinine Abnormal, Blood Urea Abnormal, Constipation, Deep Vein Thrombosis, Diarrhoea, Dyspnoea
on Jan 25, 2010 Female patient from ITALY , 64 years of age, was diagnosed with thyroid cancer (What is thyroid cancer?), neuroendocrine tumour, prostate cancer (What is prostate cancer?) and was treated with Thalomid (View Usage). Patient had the following side effects: anaemia, asthenia, blood creatinine abnormal, blood urea abnormal, constipation (What is constipation?), deep vein thrombosis (What is deep vein thrombosis?), diarrhoea, dyspnoea. Thalomid dosage: . During the same period patient was treated with INTERFERON (0.5 Million Iu) (View Interferon Review and Interferon Label ).

6570133-2 | Myelodysplastic Syndrome
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: myelodysplastic syndrome on Feb 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 132.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: .

6569561-0 | Hip Fracture
Adverse event was reported on Jan 22, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 140.1 lb, Patient experienced the following unwanted or unexpected effects: hip fracture. During the same period patient was treated with DEXAMETHASONE (Low Dose) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6551448-0 | Cough, Disease Progression, Fatigue, Oesophageal Rupture, Pregnancy, Treatment Noncompliance, Vomiting
on Jan 19, 2010 Female patient from UNITED STATES , weighting 123.1 lb, was treated with Thalomid (View Usage). Patient had the following side effects: cough, disease progression, fatigue, oesophageal rupture, pregnancy (What is pregnancy?), treatment noncompliance, vomiting. Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6549752-5 | Blood Albumin Decreased, Blood Count Abnormal, Constipation, Metastases To Pancreas, Oedema Peripheral
on Jan 13, 2010 Male patient from UNITED STATES , weighting 253.1 lb, was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: blood albumin decreased, blood count abnormal, constipation (What is constipation?), metastases to pancreas, oedema peripheral. Thalomid dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), ERLOTINIB (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6537501-6 | Phrenic Nerve Paralysis
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: phrenic nerve paralysis on Jan 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 50 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), bone disorder and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CLODRONATE DISODIUM (View Clodronate Disodium Review and Clodronate Disodium Label ).

6537298-X | Atrioventricular Block Complete
Adverse event was reported on Jan 05, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED KINGDOM , 88 years of age, Patient had the following side effects: atrioventricular block complete. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6531733-9 | Cough, Disease Progression, Fatigue, Oesophageal Rupture, Pregnancy, Treatment Noncompliance, Vomiting
on Dec 31, 2009 Female patient from UNITED STATES , weighting 123.1 lb, was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: cough, disease progression, fatigue, oesophageal rupture, pregnancy (What is pregnancy?), treatment noncompliance, vomiting. Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6530643-0 | Dementia, Orthostatic Hypotension, Paraesthesia
on Dec 31, 2009 Male patient from UNITED STATES , weighting 178.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), orthostatic hypotension, paraesthesia. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), UROXATRAL (View Uroxatral Review and Uroxatral Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALPHAGAN P (1 Drop In Both Eyes) (View Alphagan P Review and Alphagan P Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6526140-9 | Muscular Weakness, Neuropathy Peripheral, Vision Blurred
Patient was taking Thalomid (View Usage). Patient had the following side effects: muscular weakness, neuropathy peripheral, vision blurred on Dec 22, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 154.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), pain (What is pain?) and. Thalomid dosage: . During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), VICODIN (View Vicodin Review and Vicodin Label ), AMBIEN (View Ambien Review and Ambien Label ), POTASSIUM (View Potassium Review and Potassium Label ), MELATONIN (View Melatonin Review and Melatonin Label ), DECADRON (View Decadron Review and Decadron Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized and became disabled.

6521871-9 | Stent Placement
Adverse event was reported on Dec 29, 2009 by a Male patient taking Thalomid (View Usage) (Dosage: 100 Mg Qd (once Daily) Po (oral)) was diagnosed with cough, interstitial lung disease and. Location: UNITED STATES , weighting 176.4 lb, After Thalomid was administered, patient had the following side effects: stent placement. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MOTRIN (View Motrin Review and Motrin Label ), AMBIEN (View Ambien Review and Ambien Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

6517498-5 | Pneumocystis Jiroveci Pneumonia, Post Procedural Haemorrhage
on Dec 14, 2009 Female patient from INDIA , 46 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia, post procedural haemorrhage. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), OXYGEN (View Oxygen Review and Oxygen Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6503989-X | Herpes Zoster Disseminated, Reversible Posterior Leukoencephalopathy Syndrome
on Dec 11, 2009 Female patient from CANADA , weighting 156.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), herpes zoster disseminated and was treated with Thalomid (View Usage). Patient had the following side effects: herpes zoster disseminated, reversible posterior leukoencephalopathy syndrome. Thalomid dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), VALTRATE (View Valtrate Review and Valtrate Label ), DILANTIN (View Dilantin Review and Dilantin Label ). Patient was hospitalized.

6500536-3 | Haemoglobin Decreased, Myelodysplastic Syndrome, Neutrophil Count Decreased
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: haemoglobin decreased, myelodysplastic syndrome, neutrophil count decreased on Dec 05, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, . Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6492207-7 | Cough, Disease Progression, Fatigue, Oesophageal Rupture, Pregnancy, Treatment Noncompliance, Vomiting
Adverse event was reported on Dec 01, 2009 by a Female patient taking Thalomid (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 123.1 lb, Patient experienced the following unwanted or unexpected effects: cough, disease progression, fatigue, oesophageal rupture, pregnancy (What is pregnancy?), treatment noncompliance, vomiting. During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6479619-2 | Pulmonary Tuberculosis
on Nov 26, 2009 Male patient from MEXICO , 52 years of age, was diagnosed with leprosy and was treated with Thalomid (View Usage). Patient had the following side effects: pulmonary tuberculosis. Thalomid dosage: . During the same period patient was treated with DAPSONE (View Dapsone Review and Dapsone Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), CLOFAZIMINE (View Clofazimine Review and Clofazimine Label ). Patient was hospitalized.

6469070-3 | Decubitus Ulcer, Depression
on Nov 20, 2009 Male patient from JAPAN , 80 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: decubitus ulcer, depression (What is depression?). Thalomid dosage: .

6454674-4 | Haemoglobin Decreased, Myelodysplastic Syndrome, Neutrophil Count Decreased
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, myelodysplastic syndrome, neutrophil count decreased on Nov 13, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, . Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6432887-5 | Bone Marrow Failure, Disease Progression, Hyperglycaemia, Hyperviscosity Syndrome, No Therapeutic Response
Adverse event was reported on Nov 02, 2009 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), breakthrough pain and. Location: UNITED STATES , weighting 176.4 lb, Patient had the following side effects: bone marrow failure, disease progression, hyperglycaemia, hyperviscosity syndrome, no therapeutic response. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VELCADE (View Velcade Review and Velcade Label ), EFFEXOR (View Effexor Review and Effexor Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COLACE (View Colace Review and Colace Label ), COMPAZINE (View Compazine Review and Compazine Label ), PERCOCET (View Percocet Review and Percocet Label ), IMODIUM (View Imodium Review and Imodium Label ). Patient was hospitalized.

6419388-5 | Colitis Ischaemic, Pain, Sinus Tachycardia, Spinal Column Stenosis, Staphylococcal Bacteraemia, Urinary Tract Infection, Wound Infection Staphylococcal
on Oct 20, 2009 Female patient from UNITED STATES , weighting 171.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), urinary tract infection (What is urinary tract infection?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: colitis ischaemic, pain (What is pain?), sinus tachycardia, spinal column stenosis, staphylococcal bacteraemia, urinary tract infection (What is urinary tract infection?), wound infection staphylococcal. Thalomid dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), RENVELA (View Renvela Review and Renvela Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DECADRON (View Decadron Review and Decadron Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

6404862-8 | Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Deep Vein Thrombosis, Mental Status Changes, Pneumonia, Pulmonary Embolism
on Oct 12, 2009 Male patient from UNITED STATES , weighting 194.2 lb, was diagnosed with erythema nodosum leprosum, leprosy, insomnia, hypertension and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, chronic obstructive pulmonary disease, deep vein thrombosis (What is deep vein thrombosis?), mental status changes, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?). Thalomid dosage: . During the same period patient was treated with DAPSONE (View Dapsone Review and Dapsone Label ), CLOFAZIMINE (View Clofazimine Review and Clofazimine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (500/50) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PLENODIL (View Plenodil Review and Plenodil Label ). Patient was hospitalized.

6396310-1 | Blood Viscosity Increased, Disease Progression
Patient was taking Thalomid (View Usage). Patient had the following side effects: blood viscosity increased, disease progression on Oct 01, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.

6391126-4 | Cellulitis, Deep Vein Thrombosis, Dehydration, Fall, Hypotension, Multiple Myeloma, Pulmonary Artery Thrombosis, Renal Failure, Splenic Rupture
Adverse event was reported on Sep 29, 2009 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 233.7 lb, After Thalomid was administered, patient had the following side effects: cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?), dehydration, fall (What is fall?), hypotension, multiple myeloma (What is multiple myeloma?), pulmonary artery thrombosis, renal failure, splenic rupture. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), LASIX (6) (View Lasix Review and Lasix Label ), PERCOCET #300 (View Percocet #300 Review and Percocet #300 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (1/2) (View Benicar Review and Benicar Label ). Patient was hospitalized.

6390454-6 | Colitis Ischaemic, Pain, Spinal Column Stenosis, Staphylococcal Bacteraemia, Urinary Tract Infection, Wound Infection Staphylococcal
on Sep 25, 2009 Female patient from UNITED STATES , weighting 171.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), urinary tract infection (What is urinary tract infection?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic, pain (What is pain?), spinal column stenosis, staphylococcal bacteraemia, urinary tract infection (What is urinary tract infection?), wound infection staphylococcal. Thalomid dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), RENVELA (View Renvela Review and Renvela Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DECADRON (View Decadron Review and Decadron Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

6371892-4 | Disease Progression, Osteonecrosis
on Sep 15, 2009 Female patient from UNITED STATES , 78 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: disease progression, osteonecrosis (What is osteonecrosis?). Thalomid dosage: .

6366178-8 | Idiopathic Thrombocytopenic Purpura
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: idiopathic thrombocytopenic purpura on Sep 10, 2009 from CANADA Additional patient health information: Female patient , 46 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: .

6360905-1 | Cellulitis, Deep Vein Thrombosis, Dehydration, Fall, Hypotension, Multiple Myeloma, Pulmonary Artery Thrombosis, Renal Failure, Splenic Rupture
Adverse event was reported on Sep 15, 2009 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 233.7 lb, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?), dehydration, fall (What is fall?), hypotension, multiple myeloma (What is multiple myeloma?), pulmonary artery thrombosis, renal failure, splenic rupture. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), LASIX (6) (View Lasix Review and Lasix Label ), PERCOCET #300 (View Percocet #300 Review and Percocet #300 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (1/2) (View Benicar Review and Benicar Label ). Patient was hospitalized.

6357388-4 | Asthenia, Chronic Obstructive Pulmonary Disease, Clostridium Difficile Toxin Test Positive, Contusion, Hyponatraemia, Malnutrition, Nausea, Neoplasm Malignant, Pneumonia
on Sep 10, 2009 Male patient from UNITED STATES , weighting 127.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: asthenia, chronic obstructive pulmonary disease, clostridium difficile toxin test positive, contusion, hyponatraemia, malnutrition, nausea (What is nausea?), neoplasm malignant, pneumonia (What is pneumonia?). Thalomid dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), FOLATE (View Folate Review and Folate Label ), LASIX (View Lasix Review and Lasix Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6346911-1 | Atrial Fibrillation, Back Pain, Febrile Neutropenia, Lethargy, Oral Candidiasis, Unresponsive To Stimuli
on Aug 28, 2009 Male patient from UNITED STATES , 70 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), febrile neutropenia, lethargy, oral candidiasis, unresponsive to stimuli. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), POLYETHYLENE GLYCOL 3350 (View Polyethylene Glycol 3350 Review and Polyethylene Glycol 3350 Label ). Patient was hospitalized.

6346405-3 | Pneumonitis, Renal Impairment
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis, renal impairment on Aug 28, 2009 from UNITED STATES Additional patient health information: Female patient , 76 years of age, . Thalomid dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6335983-6 | Hepatic Failure
Adverse event was reported on Aug 26, 2009 by a Male patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: hepatic failure. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ). Patient was hospitalized.

6335555-3 | Asthenia, Back Pain, Bone Pain, Chronic Obstructive Pulmonary Disease, Clostridium Difficile Toxin Test Positive, Contusion, Diarrhoea, Haemoglobin Decreased, Hyponatraemia
on Aug 25, 2009 Male patient from UNITED STATES , weighting 127.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: asthenia, back pain (What is back pain?), bone pain, chronic obstructive pulmonary disease, clostridium difficile toxin test positive, contusion, diarrhoea, haemoglobin decreased, hyponatraemia. Thalomid dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), FOLATE (View Folate Review and Folate Label ), LASIX (View Lasix Review and Lasix Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6318697-8 | Cellulitis, Deep Vein Thrombosis, Dehydration, Fall, Hypotension, Pulmonary Artery Thrombosis, Renal Failure, Splenic Rupture, Urinary Tract Infection
on Aug 17, 2009 Female patient from UNITED STATES , weighting 233.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?), dehydration, fall (What is fall?), hypotension, pulmonary artery thrombosis, renal failure, splenic rupture, urinary tract infection (What is urinary tract infection?). Thalomid dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), LASIX (6) (View Lasix Review and Lasix Label ), PERCOCET #300 (View Percocet #300 Review and Percocet #300 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (1/2) (View Benicar Review and Benicar Label ). Patient was hospitalized.

6317606-5 | Failure To Thrive, Neuropathy Peripheral
Patient was taking Thalomid (View Usage). Patient had the following side effects: failure to thrive, neuropathy peripheral on Aug 11, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 175.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), back pain (What is back pain?) and. Thalomid dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERCOCET (View Percocet Review and Percocet Label ). Patient was hospitalized and became disabled.

6310395-X | Parkinson's Disease
Adverse event was reported on Aug 03, 2009 by a Male patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 74 years of age, After Thalomid was administered, patient had the following side effects: parkinson's disease (What is parkinson's disease?). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), ROPINIROLE (View Ropinirole Review and Ropinirole Label ), CARBIDOPA LEVODOPA (View Carbidopa-levodopa Review and Carbidopa-levodopa Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ).

6309740-0 | Anaemia, Anxiety, Bradycardia, Dyspnoea, Neuropathy Peripheral, Paranoia, Presyncope
on Aug 05, 2009 Male patient from UNITED STATES , weighting 200.2 lb, was diagnosed with erythema nodosum leprosum and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, anxiety (What is anxiety?), bradycardia, dyspnoea, neuropathy peripheral, paranoia, presyncope. Thalomid dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), SEPTRA (View Septra Review and Septra Label ).

6301822-2 | Blood Creatinine Increased, Diarrhoea, Disease Progression, Fatigue, Febrile Neutropenia, Hypocalcaemia, Nausea, Plasmacytoma, Respiratory Syncytial Virus Infection
on Jul 30, 2009 Female patient from UNITED STATES , weighting 139.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: blood creatinine increased, diarrhoea, disease progression, fatigue, febrile neutropenia, hypocalcaemia, nausea (What is nausea?), plasmacytoma, respiratory syncytial virus infection (What is respiratory syncytial virus infection?). Thalomid dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6292948-0 | Cardiac Failure Congestive, Left Ventricular Dysfunction, Thrombocytopenia
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: cardiac failure congestive, left ventricular dysfunction, thrombocytopenia on Jul 24, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 153.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis and. Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6285938-5 | Cellulitis, Deep Vein Thrombosis, Hypotension, Pulmonary Artery Thrombosis, Renal Failure, Splenic Rupture, Wound Necrosis
Adverse event was reported on Jul 20, 2009 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 233.7 lb, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?), hypotension, pulmonary artery thrombosis, renal failure, splenic rupture, wound necrosis. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), LASIX (6) (View Lasix Review and Lasix Label ), PERCOCET #300 (View Percocet #300 Review and Percocet #300 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (1/2) (View Benicar Review and Benicar Label ). Patient was hospitalized.

6282141-X | Acute Coronary Syndrome, Pulmonary Oedema
on Jul 17, 2009 Female patient from CANADA , weighting 141.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), peptic ulcer (What is peptic ulcer?), angina pectoris, insomnia and was treated with Thalomid (View Usage). Patient had the following side effects: acute coronary syndrome, pulmonary oedema. Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), RATIO MAGNESIUM (View Ratio-magnesium Review and Ratio-magnesium Label ), NITRO DUR (0.4 Mg/hr) (View Nitro-dur Review and Nitro-dur Label ), NITRO DUR (0.8 Mg/hr) (View Nitro-dur Review and Nitro-dur Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6279699-3 | Anaemia, Renal Disorder, Treatment Noncompliance, Uterine Leiomyoma
on Jul 14, 2009 Female patient from UNITED STATES , weighting 232.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: anaemia, renal disorder, treatment noncompliance, uterine leiomyoma. Thalomid dosage: . During the same period patient was treated with BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), FLOMAX (View Flomax Review and Flomax Label ), BENICAR (View Benicar Review and Benicar Label ), ARANESP (View Aranesp Review and Aranesp Label ), IRON (View Iron Review and Iron Label ), LASIX (View Lasix Review and Lasix Label ).

6274296-8 | Asthenia, Chronic Obstructive Pulmonary Disease, Clostridium Difficile Toxin Test Positive, Contusion, Hyponatraemia, Malnutrition, Nausea, Pneumonia, Septic Shock
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chronic obstructive pulmonary disease, clostridium difficile toxin test positive, contusion, hyponatraemia, malnutrition, nausea (What is nausea?), pneumonia (What is pneumonia?), septic shock on Jul 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 127.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), FOLATE (View Folate Review and Folate Label ), LASIX (View Lasix Review and Lasix Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6274069-6 | Chest Pain, Dehydration, Disease Progression, Dyspnoea, Muscular Weakness, Tremor
Adverse event was reported on Jul 15, 2009 by a Male patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with metastatic malignant melanoma and. Location: UNITED STATES , weighting 139.1 lb, Patient had the following side effects: chest pain (What is chest pain?), dehydration, disease progression, dyspnoea, muscular weakness, tremor. During the same period patient was treated with SENOKOT (View Senokot Review and Senokot Label ), FLOMAX (View Flomax Review and Flomax Label ), MEGACE (View Megace Review and Megace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERCOCET (View Percocet Review and Percocet Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ). Patient was hospitalized.

6271238-6 | Catheter Related Infection, Cellulitis, Clavicle Fracture, Decubitus Ulcer, Disease Progression, Occult Blood Positive, Osteomyelitis, Pneumonia Aspiration, Staphylococcal Bacteraemia
on Jul 08, 2009 Male patient from UNITED STATES , weighting 174.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: catheter related infection, cellulitis (What is cellulitis?), clavicle fracture, decubitus ulcer, disease progression, occult blood positive, osteomyelitis, pneumonia aspiration, staphylococcal bacteraemia. Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), AREDIA (View Aredia Review and Aredia Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), SINEMET (25/100) (View Sinemet Review and Sinemet Label ). Patient was hospitalized and became disabled.

6269134-3 | Asthenia, Chronic Obstructive Pulmonary Disease, Clostridium Difficile Toxin Test Positive, Nausea, Pneumonia
on Jul 10, 2009 Male patient from UNITED STATES , weighting 127.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chronic obstructive pulmonary disease, clostridium difficile toxin test positive, nausea (What is nausea?), pneumonia (What is pneumonia?). Thalomid dosage: . Patient was hospitalized.

6253175-6 | Acute Coronary Syndrome, Pulmonary Oedema
Patient was taking Thalomid (View Usage). Patient had the following side effects: acute coronary syndrome, pulmonary oedema on Jun 26, 2009 from CANADA Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), peptic ulcer (What is peptic ulcer?), angina pectoris, insomnia, hypothyroidism and. Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), RATIO MAGNESIUM (View Ratio-magnesium Review and Ratio-magnesium Label ), NITRO DUR (0.4 Mg/hr) (View Nitro-dur Review and Nitro-dur Label ), NITRO DUR (0.8 Mg/hr) (View Nitro-dur Review and Nitro-dur Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.